Bombesin/gastrin-releasing peptide antagonists RC-3095 and RC-3940-II inhibit tumor growth and decrease the levels and mRNA expression of epidermal growth factor receptors in H-69 small cell lung carcinoma
Open Access
- 1 October 1998
- Vol. 83 (7) , 1335-1343
- https://doi.org/10.1002/(sici)1097-0142(19981001)83:7<1335::aid-cncr10>3.0.co;2-5
Abstract
No abstract availableKeywords
This publication has 41 references indexed in Scilit:
- Luteinizing hormone-releasing hormone antagonist Cetrorelix (SB-75) and bombesin antagonist RC-3940-II inhibit the growth of androgen-independent PC-3 prostate cancer in nude miceThe Prostate, 1997
- Inhibition of growth of androgen-independent DU-145 prostate cancer in vivo by luteinising hormone-releasing hormone antagonist cetrorelix and bombesin antagonists RC-3940-II and RC-3950-IIEuropean Journal Of Cancer, 1997
- Characterization of bombesin/gastrin-releasing peptide receptors in membranes of MKN45 human gastric cancerCancer Letters, 1994
- Bombesin antagonists inhibit in vitro and in vivo growth of human gastric cancer and binding of bombesin to its receptorsZeitschrift für Krebsforschung und Klinische Onkologie, 1994
- Growth factor and peptide receptors in small cell lung cancerLife Sciences, 1993
- Epidermal growth factor and its receptorMolecular and Cellular Endocrinology, 1987
- Bombesin stimulation of c-fos and c-myc gene expression in cultures of Swiss 3T3 cellsExperimental Cell Research, 1986
- Epidermal growth factor receptor expression related to differentiation capacity in normal and transformed keratinocytesExperimental Cell Research, 1985
- I. High affinity receptors for bombesin/GRP-like peptides on human small cell lung cancerLife Sciences, 1985
- Gastrin releasing peptide is a selective mitogen for small cell lung carcinoma in vitro.Journal of Clinical Investigation, 1985